Three blockbuster-potential assets in late-stage clinical trials and four pivotal readouts expected in 2025; anticipate four commercial assets by 2028 Study 1 of Essential3 program for ulixacaltamide ...
Three blockbuster-potential assets in late-stage clinical trials and four pivotal readouts expected in 2025; anticipate four commercial assets by 2028 Study 1 of Essential3 program for ulixacaltamide ...
Hosted on MSN3d
Is Parkinson's Disease Infectious?Researchers do not deny that infections like influenza, herpes and Hepatitis-C an lead to Parkinson's disease. However, more ...
The Miami Neuroscience Center at Larkin Hospital in South Miami has successfully performed its first focused ultrasound ...
Since this trend caught traction, researchers started exploring the effects of drinking alcohol. The results showed that ...
Unintentional weight loss, shakes and tremors, heart palpitations, and heat intolerance are among some of the telltale signs ...
In early 2024, the World Health Organization predicted that by 2050 there will be more than 35 million new cancer cases ...
NeuroOne Medical Technologies Corporation filed an 8-K form with the Securities and Exchange Commission, announcing certain preliminary financial results for the first fiscal quarter of 2025, which ...
23hon MSN
We continued to make significant investments in healthcare technologies in the domestic and international markets, even in a ...
diagnosis can be difficult, since there is a substantial clinical overlap especially in monosymptomatic tremor (dystonic tremor, essential tremor, Parkinson tremor). The use of DAT-SPECT can prove or ...
Learn how caffeine affects Parkinson's disease prevention and treatment. New research uncovers both protective benefits and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback